The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy

Purpose: To examine whether patients with diabetic retinopathy receiving intravitreal anti-VEGF injections are at increased risk of kidney function decline. Design: Retrospective cohort study. Participants: Included 187 patients who received intravitreal anti-VEGF injections for proliferative diabet...

Full description

Bibliographic Details
Main Authors:	Casey C. Bunge, MD, Prarthana J. Dalal, MD, PhD, Elizabeth Gray, MS, Kasen Culler, MD, Julia J. Brown, MD, Susan E. Quaggin, MD, Anand Srivastava, MD, MPH, Manjot K. Gill, MD
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Ophthalmology Science
Subjects:	diabetic retinopathy diabetic macular edema intravitreal injections anti-vascular endothelial growth factor anti-VEGF
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666914523000581

Similar Items

Visual and anatomic outcomes of sustained single agent anti-VEGF treatment versus double anti-VEGF switching in the treatment of persistent diabetic macular edema
by: Osama A. Sorour, et al.
Published: (2020-06-01)

Intravitreal Injection for Diabetic Macular Edema as Adjunctive Therapy for Proliferative Diabetic Retinopathy: A Retrospective Study
by: Aljundi W, et al.
Published: (2022-01-01)

Evaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edema
by: Elena Pacella, et al.
Published: (2014-12-01)

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
by: Tianqin Wang, et al.
Published: (2021-04-01)

The Treatment of Diabetic Retinal Edema with Intravitreal Steroids: How and When
by: Maria Letizia Salvetat, et al.
Published: (2024-02-01)

A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment
by: Tsung-Cheng Hsieh, et al.
Published: (2023-05-01)

Optimal timing of preoperative intravitreal anti-VEGF injection for proliferative diabetic retinopathy patients
by: Yue Xu, et al.
Published: (2022-10-01)

Functional results one-year following the anti-VEGF therapy in macular pathology
by: Nicoleta Anton, et al.
Published: (2023-12-01)

Influence of Intravitreal Therapy on Choroidal Thickness in Patients with Diabetic Macular Edema
by: Patricia Udaondo Mirete, et al.
Published: (2023-01-01)

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
by: Levin AM, et al.
Published: (2017-01-01)

Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials
by: Singer M, et al.
Published: (2020-06-01)

Assessment of Anti-VEGFs in Treating Diabetic Macular Edema in Alfaisal Eye Center, Khartoum, Sudan, 2019
by: Ahmedalgabri RHM, et al.
Published: (2022-04-01)

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy
by: Tyler A. Bahr, et al.
Published: (2023-04-01)

Visual outcomes of observation, macular laser and anti-VEGF in diabetic macular edema in type 1 diabetes: a real-world study
by: Joonas Wirkkala, et al.
Published: (2022-06-01)

Safety and efficacy profile of intravitreal ranibizumab vs dexamethasone in treatment of naïve diabetic macular edema
by: Santosh K Mahapatra, et al.
Published: (2024-01-01)

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
by: Ume Sughra, et al.
Published: (2021-10-01)

Prefilled syringes for intravitreal drug delivery
by: Sassalos TM, et al.
Published: (2019-04-01)

Clinical Application of Intravitreal Aflibercept Injection for Diabetic Macular Edema Comparing Two Loading Regimens
by: Yoo-Ri Chung, et al.
Published: (2023-03-01)

Effect of intravitreal aflibercept on recalcitrant diabetic macular edema
by: Kendra A. Klein, et al.
Published: (2017-04-01)

The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept
by: Amy S. Babiuch, et al.
Published: (2021-11-01)

Evaluation Of Choroidal Thickness Before and After Intravitreal Injection Of Anti Vascular endothelial growth factors for Treatment Of Diabetic Macular Edema using Optical Coherence Tomography
by: Noha Mahmoud Ahmed Mohamed *, et al.
Published: (2023-07-01)

Comparison of micropulse subthreshold laser plus anti-VEGF versus anti-VEGF alone in diabetic macular edema: Systematic review
by: Parangeni M Lubis, et al.
Published: (2023-01-01)

Microperimetry and OCT angiography evaluation of patients with ischemic diabetic macular edema treated with monthly intravitreal bevacizumab: a pilot study
by: Felipe Pereira, et al.
Published: (2019-09-01)

Effect of anti-VEGF combined with laser therapy on macular blood flow density in patients with severe non-proliferative diabetic retinopathy
by: Kong-Qian Huang, et al.
Published: (2021-09-01)

Subthreshold micropulse laser versus intravitreal anti-VEGF for diabetic macular edema patients with relatively better visual acuity
by: Sezen Akkaya, et al.
Published: (2020-10-01)

Deep Learning Prediction of Response to Anti-VEGF among Diabetic Macular Edema Patients: Treatment Response Analyzer System (TRAS)
by: Saif Aldeen Alryalat, et al.
Published: (2022-01-01)

Panretinal photocoagulation after or prior to intravitreal conbercept injection for diabetic macular edema: a retrospective study
by: Wei Zhang, et al.
Published: (2021-04-01)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
by: Tran THC, et al.
Published: (2021-05-01)

Bibliometric and visualized analysis of diabetic macular edema
by: Jin Wei, et al.
Published: (2024-01-01)

Ultra-Wide-Field Fluorescein Angiography Assessment of Non-Perfusion in Patients with Diabetic Retinopathy Treated with Anti-Vascular Endothelial Growth Factor Therapy
by: Jean-Baptiste Morel, et al.
Published: (2023-02-01)

Effectiveness of prophylactic intravitreal bevacizumab injection to proliferative diabetic retinopathy patients with elevated preoperative intraocular VEGF in preventing complications after vitrectomy
by: Tsubota K, et al.
Published: (2019-06-01)

Efficacy and safety analysis of intravitreal bio-similar products of bevacizumab in patients with macular edema because of retinal diseases
by: Ruchi Agarwal, et al.
Published: (2023-01-01)

Correlation between responses to intravitreal injection of anti-VEGF and diabetic retinopathy extent in diabetic macular edema patients
by: Yue Huang, et al.
Published: (2017-02-01)

Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
by: Chang Ki Yoon, et al.
Published: (2021-01-01)

Intravitreal brolucizumab as treatment of early onset radiation retinopathy secondary to plaque brachytherapy for choroidal melanoma
by: Natacha C. Villegas, et al.
Published: (2022-09-01)

Effects of Intravitreal Bevacizumab Therapy in Patients with Proliferative Diabetic Retinopathy
by: Ribeiro de Carvalho G, et al.
Published: (2020-09-01)

Comparison of efficacy and safety of intravitreal ranibizumab and conbercept before vitrectomy in Chinese proliferative diabetic retinopathy patients: a prospective randomized controlled trial
by: Siying Li, et al.
Published: (2022-12-01)

Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients
by: Tae Hwan Moon, et al.
Published: (2022-11-01)

Effect of Intravitreal Bevacizumab Injection before Panretinal Photocoagulation on the Prevention of Macular Edema Aggravation in Proliferative Diabetic Retinopathy
by: Wungrak Choi, et al.
Published: (2020-11-01)

The Economic Burden of Diabetic Retinopathy in Jordan: Cost Analysis and Associated Factors
by: Al-Dwairi RA, et al.
Published: (2024-03-01)